Form EFFECT Checkpoint Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 4, 2025 |
| Accession Number: | 0001104659-25-054637 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DUVA Introduces DUVA ONE at IFA 2026: Personalized Sleep Earbuds That Respond in Real Time
- ETH and SOL Are Making Big Moves – Could Apeing’s Upcoming Best Crypto Presale Be the Next With Just 3 Days to Go?
- Solana Price Prediction 2030, 2040, 2050: Is $200 Next for SOL as Apeing Launch Fuels the Search for the Next Crypto to Watch?
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
